Red Blood Cell-Derived Extracellular Vesicles Display Endogenous Antiviral Effects and Enhance the Efficacy of Antiviral Oligonucleotide Therapy

Migara Kavishka Jayasinghe(National University of Singapore), Chang Gao(National University of Singapore), Gracemary Yap(National University of Singapore), Brendon Zhi Jie Yeo(National University of Singapore), Luyen Tien Vu(National University of Singapore), Douglas Jie Wen Tay(National University of Singapore), Wen Xiu Loh(National University of Singapore), Zhen Qin Aw(National University of Singapore), Huixin Chen(National University of Singapore), Dai Cao Phung(National University of Singapore), Dong Van Hoang(National University of Singapore), Rebecca Carissa Prajogo(National University of Singapore), Lissa Hooi(National University of Singapore), Fang Qing Lim(National University of Singapore), Marco Pirisinu(City University of Hong Kong), Chee Keng Mok(National University of Singapore), Kah Wai Lim(Nanyang Technological University), Sze Jing Tang(National University of Singapore), Kai Sen Tan(National University of Singapore), Edward Kai‐Hua Chow(National University of Singapore), Leilei Chen(National University of Singapore), Anh Tuân Phan(Nanyang Technological University), Justin Jang Hann Chu(Agency for Science, Technology and Research), Minh T. N. Le(Agency for Science, Technology and Research)
ACS Nano
October 18, 2023
Cited by 22Open Access
Full Text

Abstract

to suppress SARS-CoV-2 replication. Our findings indicate that this RBCEV-based SARS-CoV-2 therapeutic displays promise as a potential treatment capable of inhibiting SARS-CoV-2 entry and replication.


Related Papers

No related papers found

Powered by citation graph analysis